With Thomas N. Bulleit, Deborah Kantar Gardner, Kirsten Mayer
Donald Trump's election in 2016 placed pharmaceutical companies in uncharted territory. Unlike predecessors from both major political parties, Trump did not shy away from directly criticizing the industry.